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Introduction
Macroautophagy (which we refer to as autophagy) is a cellular 
self-cannibalistic pathway in which parts of the cytosol or 
cytoplasmic organelles are enwrapped in double-membraned 
vesicles, autophagosomes, which then fuse with lysosomes 
(Klionsky, 2007). Autophagy plays a major role in the maintenance 
of cellular homeostasis, allows for the mobilization of energy 
reserves when external resources are limited, and is essential for 
the removal of damaged organelles and potentially toxic protein 
aggregates  (Levine  and  Kroemer,  2008).  At  the  organismal 
level, autophagy can mediate cytoprotection (for instance neuro-
protection and cardioprotection in the context of ischemic pre-
conditioning; Moreau et al., 2010) and delay the pathogenic 
manifestations of aging (Levine and Kroemer, 2009). Given the 
A
utophagy protects organelles, cells, and organ-
isms against several stress conditions. Induction 
of autophagy by resveratrol requires the nico-
tinamide  adenine  dinucleotide–dependent  deacetylase 
sirtuin 1 (SIRT1). In this paper, we show that the acety-
lase inhibitor spermidine stimulates autophagy indepen-
dent of SIRT1 in human and yeast cells as well as in 
nematodes. Although resveratrol and spermidine ignite 
autophagy  through  distinct  mechanisms,  these  com-
pounds stimulate convergent pathways that culminate in 
concordant  modifications  of  the  acetylproteome.  Both 
agents favor convergent deacetylation and acetylation 
reactions in the cytosol and in the nucleus, respectively. 
Both  resveratrol  and  spermidine  were  able  to  induce   
autophagy in cytoplasts (enucleated cells). Moreover, a 
cytoplasm-restricted mutant of SIRT1 could stimulate autoph-
agy, suggesting that cytoplasmic deacetylation reac-
tions dictate the autophagic cascade. At doses at which   
neither resveratrol nor spermidine stimulated autophagy 
alone, these agents synergistically induced autophagy. 
Altogether,  these  data  underscore  the  importance  of   
an  autophagy  regulatory  network  of  antagonistic 
deacetylases and acetylases that can be pharmacologi-
cally manipulated.
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demonstrated that these agents can stimulate autophagy in a 
synergistic fashion, both in vitro, in cultured human cells, and, 
in vivo, in mice.
Results
Sirtuin-dependent versus -independent 
autophagy induced by resveratrol  
and spermidine
Spermidine and resveratrol were comparable in their autophagy 
stimulatory potency and induced hallmarks of autophagy with 
similar kinetics in human colon cancer HCT 116 cells. These 
signs included the redistribution of a GFP-LC3 chimera, which 
is usually diffuse, to cytoplasmic puncta and the lipidation of 
endogenous LC3, increasing its electrophoretic mobility (Fig. 1 
and Fig. S1 A). In these conditions, neither spermidine nor res-
veratrol impaired oxidative phosphorylation (Fig. S1 B), ruling 
out that resveratrol might induce autophagy via mitochon-
driotoxicity (Dörrie et al., 2001). Knockdown of SIRT1 with 
a specific siRNA suppressed the proautophagic activity of res-
veratrol (Fig. 1, A and B) yet failed to affect spermidine- 
induced autophagy (Fig. 1 C). Similarly, the SIRT1 inhibitor 
EX527 (Peck et al., 2010) abolished autophagy induction by 
resveratrol but not by spermidine (Fig. 1, D–F). These results 
indicate  that  resveratrol  and  spermidine  trigger  autophagy 
through distinct mechanisms.
Phylogenetic conservation of  
sirtuin-independent autophagy  
induction by spermidine
We  next  investigated  whether  the  orthologues  of  sirt1  in   
Saccharomyces cerevisiae and C. elegans (sir2 and sir-2.1, 
respectively)  are  required  for  the  proautophagic  activity  of 
spermidine. In yeast, spermidine caused the redistribution of a 
GFP-Atg8p chimera from a diffuse to a vacuolar localization 
(Fig. 2 A), the autophagy-dependent proteolytic liberation of 
GFP from GFP-Atg8p (Fig. 2 B; Suzuki et al., 2004), as well 
as an autophagy-related increase in vacuolar AP (Fig. 2 C; 
Noda et al., 1995). These effects were similar in wild-type 
(WT) and sir2 yeast strains (Fig. 2, A–C). Moreover, spermi-
dine significantly improved the survival of aging WT yeast cul-
tures,  a  beneficial  effect  that  was  attenuated,  yet  remained 
significant, in aging sir2 yeast cultures (Fig. 2 D). Accord-
ingly, spermidine reduced the aging-associated overproduction 
of reactive oxygen species (measured by assessing the conver-
sion of nonfluorescent dihydroethidine into fluorescent ethid-
ium) both in WT and sir2 cells (Fig. 2 E). In C. elegans 
embryos,  spermidine  induced  the  autophagy-related  expres-
sion and cytoplasmic aggregation of DsRed::LGG-1 (Fig. 3,   
A and B; Eisenberg et al., 2009). This effect was significant in 
both WT and sir-2.1 mutant nematodes, although the sir-2.1 
mutation attenuated autophagy induction by spermidine (Fig. 3, 
C and D). Consistently, spermidine prolonged the lifespan of 
WT and sir-2.1–deficient worms by 18 and 13%, respectively. 
Collectively, these results indicate that spermidine can stimu-
late autophagy and extend the lifespan of yeast cells and nema-
todes that lack SIRT1 orthologues.
potential health and longevity-promoting effects of autophagy, 
pharmacological agents that stimulate autophagy at a low level 
of toxicity are urgently needed.
Rapamycin and the so-called rapalogs are the most effec-
tive clinically used inducers of autophagy yet have severe   
immunosuppressive effects (Hartford and Ratain, 2007). Thus, 
alternative, nontoxic autophagy inducers (such as rilmenidine 
or carbamazepine) are being characterized for their pharmaco-
logical profile in suitable preclinical models (Hidvegi et al., 
2010; Rose et al., 2010). Nontoxic compounds, such as resvera-
trol and spermidine, are also being evaluated for their potential 
to induce autophagy in vivo (Eisenberg et al., 2009; Morselli   
et al., 2010). Resveratrol is a natural polyphenol found in grapes, 
red wine, berries, knotweed, peanuts, and other plants. The in-
terest in this molecule rose because it was suggested to mediate 
the cardioprotective effects of red wine (Baur and Sinclair, 2006). 
Resveratrol is also a potent inducer of autophagy (Scarlatti   
et al., 2008a,b), and this effect is mediated through the activa-
tion of sirtuin 1 (SIRT1), a NAD
+-dependent deacetylase (Morselli 
et al., 2010). Resveratrol has been suggested to directly activate 
SIRT1 (Baur and Sinclair, 2006; Lagouge et al., 2006), although 
indirect  effects  may  actually  be  preponderant  (Beher  et  al., 
2009; Pacholec et al., 2010). Spermidine is polyamine found in 
citrus fruit and soybean, which has recently been shown to in-
crease the lifespan of yeast, nematodes, and flies in an autophagy-
dependent fashion (Eisenberg et al., 2009).
The transfection-enforced expression of SIRT1 is suffi-
cient to stimulate autophagy in human cells (Lee et al., 2008). 
Starvation-induced autophagy (but not autophagy induced by 
rapamycin) requires SIRT1, both in vitro (in mammalian cells; 
Lee et al., 2008) and in vivo (in Caenorhabditis elegans; Morselli 
et al., 2010). Activated SIRT1 induces autophagy via its capac-
ity to deacetylate acetyl lysine residues in other proteins (Lee   
et al., 2008). Conversely, knockdown of the acetyltransferase 
EP300 (Lee and Finkel, 2009), as well as inhibition of histone 
acetylases, potently induces autophagy (Eisenberg et al., 2009), 
indicating that protein deacetylation may play a general role in 
the initiation of the autophagic cascade. EP300 acetylates sev-
eral autophagy-relevant proteins, including autophagy-related 5 
(ATG5), ATG7, ATG12, and microtubule-associated protein 1 
light chain 3  (LC3; Lee and Finkel, 2009), whereas SIRT1 
deacetylates ATG5, ATG7, LC3 (Lee et al., 2008), and the 
transcription factor forkhead box O3, which can stimulate the   
expression of proautophagic genes (Kume et al., 2010). As a 
result, protein (de)acetylation reactions influenced by sirtuins 
and  other  enzymes  control  autophagy  at  multiple  levels,   
including the modification of autophagy core proteins and/or 
of transcriptional factors that control the expression of auto-
phagic genes.
Driven by these premises and incognita, we comparatively 
assessed the mechanisms of autophagy induction mediated by 
two  distinct  compounds  that  modulate  protein  acetylation, 
namely resveratrol and spermidine. We found that both agents 
induce autophagy through initially distinct yet convergent   
pathways that culminate in the acetylation and deacetylation 
of hundreds of proteins, with opposed patterns in distinct 
subcellular compartments. Based on this characterization, we 617 Pharmacological modulation of autophagy • Morselli et al.
not result in higher levels of autophagy than that of either agent 
alone (Fig. 4 D). This kind of epistatic analysis confirms the 
suspected convergence of the proautophagic pathways elicited 
by both agents.
Convergent action of resveratrol and 
spermidine on the acetylproteome
Next, we comparatively explored the effects of resveratrol and 
spermidine on the acetylation patterns of cytosolic, mitochondrial, 
and nuclear proteins. To that purpose, we performed stable isotope 
labeling with amino acids in cell culture (SILAC) and then puri-
fied the proteins/peptides containing acetylated lysine residues 
and identified them by quantitative mass spectrometry (MS). Res-
veratrol or spermidine induced changes in the acetylation of 560 
lysine-containing motifs corresponding to 375 different proteins 
(Table S1). Surprisingly, 170 proteins whose acetylation status 
was modified in response to resveratrol or spermidine treatment 
are part of the recently elucidated human autophagy protein net-
work (Behrends et al., 2010). Many of the (de)acetylated proteins 
identified in our study are central to the network because 89 among 
them interact with at least 10 proteins in the network (Table S2).
Both resveratrol and spermidine tended to induce the 
(de)acetylation of similar proteins, including that of autophagy-
relevant substrates, such as ATG5 and LC3 (Fig. 5, A and B; 
Resveratrol and spermidine induce 
autophagy through convergent pathways
To investigate the signal transduction pathway stimulated by 
resveratrol and spermidine, the phosphorylation status of multi-
ple cellular proteins was analyzed in human colon cancer HCT 
116 cells by means of an antibody array. Surprisingly, spermi-
dine and resveratrol, alone or in combination, elicited similar 
changes in the phosphorylation status of multiple kinases and 
their substrates (Fig. 4, A–C). For example, both spermidine 
and resveratrol mediated the dephosphorylation of the protein 
tyrosine  kinase  2    (also  known  as  PYK2)  and  the  cyclin- 
dependent kinase inhibitor 1B (better known as p27
Kip1). How-
ever,  neither  of  the  two  agents  had  major  effects  on  the 
phosphorylation  levels  of  the  regulatory  subunit  of AMP- 
dependent kinase and its substrate acetyl–coenzyme A (CoA) 
carboxylase, which was in line with the hypothesis that the en-
ergy metabolism of the cells was normal. Moreover, spermidine 
and resveratrol did not affect the phosphorylation of mechanis-
tic target of rapamycin (mTOR) nor that of its substrate ribo-
somal protein S6 kinase (also known as p70
S6K; Fig. 4, A–C), 
which suggests that resveratrol and spermidine induce autoph-
agy through AMP-dependent kinase/mTOR-independent con-
vergent pathways. Accordingly, the administration of an optimal 
dose of resveratrol and spermidine (100 µM for both agents) did 
Figure 1.  SIRT1 activity is required for resveratrol-induced autophagy but not for spermidine-mediated autophagy induction in mammalian cultured cells. 
(A–C) Human colon carcinoma HCT 116 cells were left untransfected (Co, control) or transfected with an irrelevant siRNA (UNR, unrelated) or siRNAs 
specific for ATG5, ATG7, or SIRT1 and then retransfected with a GFP-LC3–encoding plasmid, cultured in complete medium for 24 h, and left untreated 
or treated for 4 h with 100-µM resveratrol (Resv) or spermidine (Spd). The same experiment was performed in the presence of bafilomycin A1 (BafA1), 
which inhibits the fusion between lysosomes and autophagosomes, to evaluate the autophagic flux. (A) Representative images. (B) Quantitative data.   
(C) Representative immunoblots of HCT 116 cells transfected either with an unrelated siRNA or with a SIRT1-specific siRNA showing LC3 lipidation after 
treatment with 100-µM spermidine in the presence or absence of bafilomycin A1. (D–F) HCT 116 cells were left transfected with a GFP-LC3 plasmid, 
cultured in complete medium for 24 h, and treated with either vehicle (Co), 100-µM resveratrol, or 100-µM spermidine in the presence or absence of the 
SIRT1 inhibitor EX527 for 4 h. (D) Representative images. (E) Quantitative data. (B and E) Bars depict the percentages of cells showing accumulation of 
GFP-LC3 in puncta (GFP-LC3
vac; means ± SEM; n = 3; *, P < 0.05). (F) Representative immunoblots showing LC3 lipidation in HCT 116 cells treated with 
100-µM spermidine in the presence or absence of EX527. GAPDH, glyceraldehyde 3-phosphate dehydrogenase.JCB • VOLUME 192 • NUMBER 4 • 2011   618
Figure 2.  The lifespan-extending and autophagy-inducing effects of spermidine in yeast are not mediated by Sir2. (A–E) EGFP-Atg8p was ectopically 
expressed in wild-type (WT) or sir2 S. cerevisiae undergoing chronological aging on small synthetic 2% glucose media with or without (Co, control) 
supplementation of 4-mM spermidine (Spd). (A) Representative images. EGFP-Atg8p localization (bottom) was visualized by fluorescence microscopy. Yeast 
cells undergoing autophagy (in which EGFP-Atg8p exhibits a prominent vacuolar localization) are indicated by arrows. Yeast morphology was monitored 
by differential interference contrast (DIC; top). (B) Representative immunoblots against EGFP. Free EGFP indicates the vacuolar degradation of EGFP-Atg8p 
fusion, thereby representing the autophagic flux. Notice that both WT and sir2 yeast cells show similar free EGFP levels after spermidine-mediated   
autophagy induction. (C) Relative alkaline phosphatase (ALP) activity indicative of autophagy. n = 3. (D) Survival data. n = 4. (E) Quantification of reactive 
oxygen species. Bars indicate the percentages of cells exhibiting the reactive oxygen species–mediated conversion of dihydroethidine (DHE) into ethidium 
(Eth; n = 4). Data represent means ± SEM; *, P < 0.001 as compared with untreated cells of the same genotype. GAPDH, glyceraldehyde 3-phosphate 
dehydrogenase. RFU, relative fluorescence unit.619 Pharmacological modulation of autophagy • Morselli et al.
induction by spermidine and/or resveratrol is a transcription-
dependent or -independent event using cytoplasts (enucleated 
cells). Cytoplasts were still able to accumulate GFP-LC3 puncta in 
response to spermidine or resveratrol treatment (Fig. 8, A and B), 
indicating that nuclei (and by extension transcription) are not 
required  for  short-term  autophagy  stimulation  by  these  two 
agents. Next, we enforced overexpression of transgenic WT 
SIRT1 (which although preponderantly localizes to the nucleus, 
has been reported to efficiently shuttle to the cytoplasm; Tanno 
et al., 2007) or that of a mutant SIRT1 protein with a muta-
tion in the nuclear localization signal (which is, therefore, virtu-
ally  restricted  to  the  cytoplasm;  Fig.  8  C).  Both  constructs 
and Fig. S2 E). Interestingly, no fundamental differences were 
found in the consensus (de)acetylation sites that were modified 
in response to resveratrol or spermidine (Fig. 6 and Fig. 7). In 
the cytosol, resveratrol and spermidine induced convergent 
deacetylation more frequently than convergent acetylation, 
whereas in the nucleus, acetylation was dominantly triggered 
by both agents (Fig. 5 B, P < 0.001, 
2 test). Moreover, when we 
analyzed the distinct biological processes associated with the 
observed (de)acetylated proteins after gene ontology (GO) term 
enrichment (Ashburner et al., 2000), deacetylated proteins often 
fell in the category of metabolism (which includes autophagy; 
Fig. S3). Therefore, we investigated whether short-term autophagy 
Figure 3.  The life-extending and autophagy-inducing effects of spermidine in C. elegans are not mediated by Sir2. (A) Fluorescence microscopy of   
C. elegans transgenic embryos expressing a full-length plgg-1DsRed::LGG-1 fusion protein indicative of autophagic activity. Two representative pictures of 
wild-type (WT) and sir-2.1 embryos untreated (Co, control) or treated with 0.2-mM spermidine (Spd) supplementation of food are shown. (B) Quantification 
of autophagic activity through the measurement of DsRed::LGG-1 pixel intensity from images of WT animals shown in A. Data represent means ± SEM   
(n = 3) with ≥25 images processed for each trial. (C) Survival of WT C. elegans during aging with and without (control) supplementation of food (UV-killed 
E. coli) with 0.2-mM spermidine (n = 110; P < 0.005). (D) Survival of sir-2.1 C. elegans (ok434 phenotype) during aging with and without (control) 
supplementation of food (UV-killed E. coli) with 0.2-mM spermidine (n = 110; P < 0.01). P-values were calculated using the log-rank test as described in 
Materials and methods.JCB • VOLUME 192 • NUMBER 4 • 2011   620
two agents at low doses (10 µM) was able to significantly   
up-regulate  autophagic  flux,  the  combination  of  spermidine 
and resveratrol at low doses (10 µM) was as efficient in enhanc-
ing  GFP-LC3  puncta  formation,  LC3  lipidation,  and  an  in-
crease in autophagic flux as were high doses of spermidine or 
resveratrol (Fig. 9, A and B).
To try to extend these results to a physiological setting, 
we  intraperitoneally  injected  optimal  doses  of  resveratrol   
(25 mg/kg) or spermidine (50 mg/kg) into mice expressing a 
GFP-LC3 transgene to induce autophagy in an array of or-
gans. One tenth of this optimal dose (2.5 mg/kg resveratrol 
or 5 mg/kg spermidine) had no major proautophagic effect in 
vivo when either compound was injected alone. However, 
the combination of low doses of both agents was highly effi-
cient  in  triggering  autophagy  in  vivo  (Fig.  9,  C  and  D).   
Similar results were obtained when these agents were in-
jected into WT mice, as shown by means of LC3 lipidation 
and p62 degradation (Fig. 9 E). In conclusion, low doses of 
spermidine and resveratrol can induce autophagy in a syner-
gistic fashion.
induced RFP-LC3 punctuation and LC3 lipidation with simi-
lar potency and similar kinetics (Fig. 8, C–E), suggesting 
that autophagy can be efficiently regulated by cytoplasmic 
(de)acetylation reactions.
Synergistic induction of autophagy by low 
doses of resveratrol and spermidine
Resveratrol (but not spermidine) induces autophagy through 
the activation of the deacetylase SIRT1 (Morselli et al., 2010), 
whereas spermidine is thought to act as an inhibitor of acety-
lases (Eisenberg et al., 2009). We reasoned that low doses of 
resveratrol  and  spermidine  might  synergistically  induce  au-
tophagy by affecting the equilibrium state of (de)acetylation. 
To assess this possibility, we treated HCT 116 cells with differ-
ent  concentrations  of  resveratrol  or  spermidine,  alone  or  in 
combination, and analyzed the effects of the different pharma-
cological combinations in terms of autophagy induction. As 
expected, both spermidine and resveratrol used at high doses 
(100 µM) induced GFP-LC3 punctuation and LC3 lipidation 
(Fig. 9 A) in cultured cells. Interestingly, although none of the 
Figure 4.  Convergent alterations in the phos-
phoproteome  status  after  resveratrol  and/or 
spermidine  treatment.  (A–C)  Human  colon 
carcinoma HCT 116 cells were treated for 2 h 
with vehicle (Co, control), 100-µM resveratrol 
(Resv), and 100-µM spermidine (Spd), alone 
or in combination (Resv + Spd). (A) Repre-
sentative  phosphoprotein  arrays  are  shown. 
(B) Clustering analysis for the effects on protein 
kinase  phosphorylation.  (C)  Representative 
immunoblots of selected kinases whose phos-
phorylation  status  was  unaffected  (PRKAA1, 
RPS6KB1,  and  acetyl-CoA  carboxylase  a 
[ACACA]) or affected by resveratrol or/and 
spermidine  treatment  (PTKB,  AKT1,  MAPK8, 
and  CDKN1B),  validating  phosphoprotein 
array data. (D) Human colorectal carcinoma 
HCT 116 cells were transfected with a GFP-
LC3–encoding plasmid, cultured in complete 
medium for 24 h, and then treated with either 
vehicle or the indicated dose of resveratrol or 
spermidine, alone or in combination, for 2 h. 
Quantitative  data.  Bars  depict  the  percent-
ages (means ± SD; n = 3; *, P < 0.05) of   
cells showing the accumulation of GFP-LC3 in   
puncta  (GFP-LC3
vac).  GAPDH,  glyceraldehyde   
3-phosphate dehydrogenase.621 Pharmacological modulation of autophagy • Morselli et al.
Discussion
Resveratrol can induce autophagy only in the presence of SIRT1 
(Morselli et al., 2010), whereas SIRT1 (or its orthologues in 
yeast and nematodes) is dispensable for spermidine-stimulated 
autophagy. Thus, these agents clearly ignite distinct pathways 
across a large phylogenetic distance. In spite of the difference in 
the primary targets of resveratrol and spermidine, both agents 
activated convergent pathways in that thus far they both stimu-
lated mTOR-independent autophagy and elicited rather similar 
changes in the phosphoproteome and, more importantly, in the 
acetylproteome. Both agents provoked multiple changes (in-
creases or decreases) in the lysine acetylation of hundreds of 
proteins, and the convergent changes induced by both agents 
largely outnumbered discordant modifications. When combined 
between each other, high doses of spermidine and resveratrol 
did not induce higher levels of autophagy than each of the two 
agents alone, which is in line with the idea that the terminal 
pathways stimulated by these compounds overlap. Spermidine 
and resveratrol modulated the acetylation of >100 proteins that are 
part of the central network of autophagic regulators/executioners 
(Behrends et al., 2010). This suggests that both agents stimulate 
autophagy through a multipronged mechanism that involves a 
large number of (de)acetylation reactions.
Although  resveratrol  can  (directly  or  indirectly)  activate 
SIRT1, a deacetylase (Baur and Sinclair, 2006; Lagouge et al., 
2006; Beher et al., 2009; Pacholec et al., 2010), spermidine has 
been shown to inhibit acetylases (Erwin et al., 1984; Eisenberg   
et al., 2009). Based on this consideration, it appears paradoxical 
that neither of these two agents was able to provoke a general 
deacetylation state and that both of them actually stimulated a 
similar shift in the acetylation pattern, in which hundreds of pro-
teins were deacetylated (more in the cytosol than in the nucleus), 
whereas several others were acetylated (more in the nucleus than 
in the cytosol). Cells harbor multiple deacetylases and acetylases 
(Hassig and Schreiber, 1997; Katan-Khaykovich and Struhl, 2002; 
Nakamura et al., 2010), and it appears plausible, yet remains to be 
proven, that inhibition of one (or a few) acetylase will activate 
compensatory  reactions  by  other  acetylases  and/or  impact  the   
action of deacetylases so that the global cellular level of protein 
acetylation remains near to constant. As a significant trend, how-
ever, we observed that both resveratrol and spermidine stimulated 
the deacetylation of cytosolic proteins, such as ATG5 and LC3, and 
the acetylation of nuclear proteins, including multiple histones.
It has been recently reported that lifespan extension by sper-
midine treatment (during conditions of chronological aging) is 
linked to deacetylation of nuclear histones and to an increase in the 
transcription of different autophagy-related genes (Eisenberg et al., 
2009). Interestingly, autophagy was rapidly induced by both sper-
midine and resveratrol in cytoplasts prepared from proliferating 
human cells, and an extranuclear variant of SIRT1 was as efficient 
in inducing autophagy as the predominantly nuclear WT SIRT1. 
Collectively,  these  data  suggest  that  protein  deacetylation  first 
stimulates autophagy predominantly through a cytosolic mecha-
nism. These results not only illustrate the differences between qui-
escent and proliferating cells in terms of autophagy modulation but 
also suggest that after a fast and nuclear-independent autophagic 
Figure  5.  Convergent  acetylproteome  modification  after  resveratrol  or 
spermidine treatment. (A–C) Colon carcinoma HCT 116 cells were cultured 
for 2 wk in three different SILAC media containing different arginine and 
lysine isotopes. Cells were treated with 100-µM resveratrol (Resv) or spermi-
dine (Spd) for 2 h, fractioned into cytoplasmic, nuclear, and mitochondrial 
extracts, processed for acetyl lysine peptide enrichment, and analyzed by 
MS. (A) Hierarchical clustering of drug-specific organellar distributions of all 
acetylated sites quantified in at least one fraction. Fold changes are calcu-
lated relative to untreated cells. Only sites regulated >1.5-fold were included 
in statistical analyses. (B) Graphical representation of peptides whose acety-
lation status was affected in a convergent or divergent way. n = 560.JCB • VOLUME 192 • NUMBER 4 • 2011   622
Figure 6.  Significant motifs among sites undergoing acetylation. (A) Hierarchical clustering of the organellar distributions of sites whose acetylation was 
increased by >1.5-fold in response to resveratrol or spermidine, at least in one organellar fraction. (B) Consensus acetylation motifs identified upon res-
veratrol (left) or spermidine (right) treatment are depicted using the MotifX algorithm (Schwartz and Gygi, 2005). Among sites that were hyperacetylated 
in response to both agents, the K(F/Y) motif is significantly enriched when tested against the whole proteome (P < 0.00001). (C) When testing against the 
largest acetylation site dataset from Choudhary et al. (2009) (acetylation background dataset [ABD]), the SxK motif is significant (P < 0.0001) for sites 
whose acetylation increased upon spermidine treatment. No general consensus motifs were found for sites whose acetylation increased in response to 
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Figure 7.  Significant motifs among sites undergoing deacetylation. (A) Hierarchical clustering of the organellar distributions of sites whose deacetylation 
was increased by >1.5-fold in response to resveratrol or spermidine, at least in one organellar fraction. (B) Among sites that were hypoacetylated in re-
sponse to both agents, the KP motif is significantly enriched when tested against ABD (P < 0.001). (C and D) When tested against the ABD (C) or the whole 
proteome (D), the KP motif is significant for sites undergoing hypoacetylation upon spermidine treatment (P < 0.0001). No general consensus motifs were 
found for sites whose acetylation decreased in response to both agents.JCB • VOLUME 192 • NUMBER 4 • 2011   624
Resveratrol is a natural polyphenol contained in red wine 
and vegetables, whereas spermidine is a polyamine found in 
other healthy food, such as citrus fruit and soybean. When ana-
lyzed as individual compounds, neither polyphenols nor poly-
amines consumed with the normal diet may reach concentrations 
high enough to mediate pharmacological effects. Nonetheless, 
it is tempting to speculate that combinations of these agents—
and perhaps that of other proautophagic dietary components—
may affect the autophagic rheostat, as based on their distinct yet 
convergent mode of action.
Materials and methods
Chemical, cell line, and culture conditions
Unless otherwise specified, chemicals were purchased from Sigma-Aldrich, 
culture media and supplements for cell culture were obtained from Invitro-
gen, and plasticware was purchased from Corning. Human colon carci-
noma HCT 116 cells (gift from B. Volgelstein, Howard Hughes Medical 
response transcriptional reprogramming is required to maintain an 
increased basal autophagic activity (Kroemer et al., 2010), thus 
contributing to the previously reported lifespan extension.
Although we have few mechanistic cues to understand the 
discrepancy in cytosolic versus nuclear (de)acetylation reac-
tions induced by resveratrol and spermidine, it is tempting to 
explain the synergistic proautophagic action of both compounds 
by the network properties of acetylases and deacetylases. One 
tenth of the dose of spermidine or resveratrol, which optimally 
stimulates autophagy, has no major proautophagic effects, mean-
ing that dose–response curves are rather steep (most likely 
caused by compensatory reactions that tend to maintain the   
homeostasis of the acetylproteome). However, the partial yet si-
multaneous activation of the deacetylase activity of SIRT1 by 
resveratrol and the concomitant inhibition of acetylases by sper-
midine can unbalance the acetylproteome, thereby synergisti-
cally stimulating autophagy.
Figure 8.  Autophagy can be efficiently regulated by cytoplasmic (de)acetylation reactions. (A and B) HCT 116 cells were transfected with a GFP-LC3– 
encoding plasmid, cultured in complete medium for 24 h, and enucleated to obtain cytoplasts. The cytoplasts were treated with either vehicle (Co, control), 
100-µM resveratrol (Resv), or 100-µM spermidine (Spd) for 4 h. 1-µM rapamycin (Rapa) was used as a positive control. (A) Representative images   
of cytoplasts indicative of autophagic activity. Arrows indicate GFP-LC3–transfected cytoplasts, whereas insets show nonenucleated transfected cells.   
(B) Quantitative data. Bars show the percentages of cells or cytoplasts showing the accumulation of GFP-LC3 in puncta (GFP-LC3
vac). (C–E) HCT 116 cells 
were cotransfected with a plasmid for the expression of RFP-LC3 together with an empty vector (pcDNA3) or plasmids encoding wild-type (WT) SIRT1 or a 
SIRT1 variant with a mutation in the nuclear localization signal fused to GFP (WT GFP-SIRT1 and mtNLS GFP-SIRT1, respectively) for 12 or 24 h, fixed, and 
analyzed by fluorescence microscopy. (C) Representative images indicative of 24-h autophagic activity. (D) Quantitative data. Bars depict the percentages 
of cells exhibiting the accumulation of RFP-LC3 in puncta (RFP-LC3
vac). (B and D) Means ± SEM; n = 3; *, P < 0.05. (E) Representative immunoblots for 24-h 
endogenous LC3 lipidation. The asterisk stands for a nonspecific band. GAPDH, glyceraldehyde 3-phosphate dehydrogenase.625 Pharmacological modulation of autophagy • Morselli et al.
Figure 9.  Low doses of resveratrol and spermidine synergistically induce autophagy in vitro and in vivo. (A) Human colorectal carcinoma HCT 116 cells were 
transfected with a GFP-LC3–encoding plasmid, cultured in complete medium for 24 h, and then treated with either vehicle (Co, control) or the indicated dose of 
resveratrol (Resv) or spermidine (Spd), alone or in combination, for 2 h. (top) Quantitative data. Bars depict the percentages (means ± SD; n = 3; **, P < 0.05) 
of cells showing the accumulation of GFP-LC3 in puncta (GFP-LC3
vac). (bottom) Representative immunoblots showing endogenous LC3 lipidation. (B) Representative 
immunoblots showing endogenous LC3 lipidation in the presence of bafilomycin A1 (BafA1). (C–E) Transgenic C57BL/6 mice expressing a GFP-LC3 fusion protein 
were injected with resveratrol and spermidine at the indicated concentrations. 3 h later, mice were killed, and tissues were processed for immunofluorescence 
microscopy determinations of GFP-LC3
vac. (C) Representative images. (D) Quantitative results. Bars represent the percentages (means ± SEM; n = 3; *, P < 0.05; 
and **, P < 0.01 as compared with the same tissue from untreated animals) of cells exhibiting GFP-LC3
vac. (E) Representative immunoblots showing endogenous 
LC3 lipidation and p62 protein content in WT C57BL/6 mouse tissues. GAPDH, glyceraldehyde 3-phosphate dehydrogenase.JCB • VOLUME 192 • NUMBER 4 • 2011   626
Technology), ATG7 (Sigma-Aldrich), phosphocyclin-dependent kinase in-
hibitor 1B (Abcam), TP53 (DO7), p62, SIRT1 (Santa Cruz Biotechnology), 
and peptidylprolyl isomerase A (cyclophilin A; Enzo Life Sciences, Inc.). 
Revelation was performed with appropriate HRP-labeled secondary anti-
bodies (SouthernBiotech) plus a chemoluminescent substrate (SuperSignal 
West Pico; Thermo Fisher Scientific). An antiglyceraldehyde-3 phosphate 
dehydrogenase antibody (Millipore) was used to control the equal loading 
of lanes. For immunoprecipitation, extracts from 8 × 10
6 cells were lysed, and 
500 µg of protein was precleaned for 1 h with 15 µl protein G–Sepharose 4 
Fast Flow (GE Healthcare) followed by incubation for 2 h in the presence 
of an antiacetylated lysine (Cell Signaling Technology) antibody. Subse-
quent immunoblotting was performed by means of TrueBlot-HRP (eBio-
science)  secondary  antibodies.  For  phosphokinase  array  analyses,  the 
Proteome Profiler kit (R&D Systems) was used according to the manufac-
turer’s instructions.
Yeast aging and autophagy measurements
For chronological aging experiments, WT BY4741 (MATa his31 leu20 
met150  ura30)  S.  cerevisiae  or  the  respective  sir2  deletion  mutant 
(sir2) from the European Saccharomyces Cerevisiae Archive for Func-
tional Analysis were inoculated from fresh overnight cultures to an absor-
bance of 0.1 (10
6 cells/ml) and grown at 28°C on Synthetic Complete 
2% glucose medium. Aliquots were taken to perform survival plating at the 
indicated time points (Fig. 2 D, line graph) as previously described (Herker 
et al., 2004). Representative aging experiments are shown with at least 
three independent samples. Spermidine was added to stationary cultures 
at day 1 of the aging experiments (Eisenberg et al., 2009). Dihydroethid-
ium staining was performed as previously described (Büttner et al., 2007), 
and the superoxide-driven conversion to ethidium was quantified either on 
a fluorescence plate reader (GeniosPro; TECAN) or on a cytofluorometer 
(FACSAria; BD) followed by first-line statistical analysis by means of the 
FACSDiva software (BD). Autophagy was monitored by vacuolar localiza-
tion of Atg8p using fluorescence microscopy or by immunoblotting of cells 
ectopically expressing an EGFP-Atg8 chimera (Eisenberg et al., 2009) with 
anti-GFP (Sigma-Aldrich) and antiglyceraldehyde-3 phosphate dehydroge-
nase antibodies. For biochemical quantifications of the autophagic flux, AP 
activity was assayed according to published methods (Noda et al., 1995). 
In brief, WT or sir2 BY4741 cells were transformed and selected for sta-
ble  insertion  of  a  pTN9  HindIII  fragment  encoding  for  the  cytosolic 
Pho8N60 protein. AP activity was then assessed in 1.5 µg of crude pro-
tein extracts by measuring the conversion of a-naphtyl phosphate to naph-
thalene using a GeniosPro fluorescence plate reader with excitation and 
emission wavelengths at 340 nm and 485 nm, respectively (Noda et al., 
1995). To correct for intrinsic AP activity, WT or sir2 yeast cells lacking 
the pTN9 HindIII fragment were simultaneously assayed, and these values 
were used for background subtraction, giving the vacuolar (autophagic) 
AP activity.
C. elegans strains, genetics, and pharmacology
We  followed  standard  procedures  for  C.  elegans  strain  maintenance. 
Nematode-rearing temperature was kept at 20°C. The following strains 
were used in this study: N2, WT Bristol isolate, and VC199, sir-2.1(ok434)IV. 
The VC199 strain was provided by the C. elegans Gene Knockout Proj-
ect at the Oklahoma Medical Research Foundation, which is part of   
the  International  C.  elegans  Gene  Knockout  Consortium  and  the  Cae-
norhabditis Genetics Center and is funded by the National Institutes of   
Health  National  Center  for  Research  Resources.  The  construction  of   
the plgg-1DsRed::LGG-1 reporter plasmid has been described previously   
(Samara et al., 2008). Spermidine was dissolved in sterilized water to a 
stock solution concentration of 100 mM. Escherichia coli (OP50) bacteria 
on seeded nematode growth medium (NGM) plates were killed by UV irra-
diation for 10 min (0.5 J) using a UV cross-linker (Bio-Link BLX-E365; Vilber 
Lourmat). A range of spermidine concentrations was prepared by dilutions 
in 100 µl of sterilized water and applied to the top of the agar medium   
(7-ml NGM plates). Plates were then gently swirled to allow the drug to 
spread to the entire NGM surface. Identical drug-free water solutions were 
used for the control plates. Plates were then allowed to dry overnight. The 
procedure was repeated each time worms were transferred to fresh plates 
(every 2–3 d during the first 2 wk and every week thereafter). Worms were 
incubated at 20°C.
C. elegans autophagy measurements
Images  from  transgenic  embryos  expressing  a  DsRed::LGG-1  fusion 
protein were acquired using a 540 ± 15–nm band-pass excitation filter 
and a 575-nm long-pass emission filter. Experiments were performed at 
20°C, with photography exposure time kept identical for each embryo. 
Institute, Johns Hopkins University, Baltimore, MD; Bunz et al., 1999) were 
cultured in McCoy’s 5A medium containing 10% fetal bovine serum, 
100 mg/liter sodium pyruvate, 10-mM Hepes buffer, 100 U/ml penicillin 
G sodium, and 100 µg/ml streptomycin sulfate (5% CO2 at 37°C). Cells 
were seeded in 6- and 12-well plates or in 10- and 15-cm dishes and 
grown for 24 h before treatment with 10-µM EX527 (Tocris Bioscience), 
10- or 100-µM resveratrol, 10- or 100-µM spermidine, and 1-µM rapa-
mycin or 1-nM bafilomycin A1 (Tocris Bioscience) for the time indicated in 
each experimental figure legend.
Plasmids, transfection, and RNA interference in human cell cultures
Cells were cultured in 12-well plates and transfected at 50% confluence 
with siRNAs targeting human SIRT1 (Ford et al., 2005), ATG5, or ATG7 
(Thermo Fisher Scientific) or with an unrelated control siRNA by means of 
a transfection reagent (Oligofectamine; Invitrogen) following the manufac-
turer’s instructions. After 24 h, cells were transfected with a plasmid coding 
for a GFP-LC3 fusion (Kabeya et al., 2000). Transient plasmid transfections 
were performed with the Attractene reagent (QIAGEN) as suggested by 
the manufacturer, and unless otherwise indicated, cells were analyzed 24 h 
after transfection. Cells were transfected with a plasmid coding for RFP 
fused to LC3 (RFP-LC3; obtained from Invitrogen) in the presence of an 
empty vector (pcDNA3) or of different constructs for the overexpression of 
GFP-tagged WT SIRT1 or a SIRT1 variant mutated in the nuclear localization 
signal, which mostly localizes in the nucleus (Tanno et al., 2007). For fluor-
escence microscopy determinations, cells cultured on coverslips were fixed in 
paraformaldehyde (4% wt/vol) for 15 min at RT, washed three times in PBS, 
and mounted with mounting medium (Vectashield; Vector Laboratories).
Fluorescence microscopy
Confocal fluorescent images were captured using a confocal fluorescence 
microscope (TCS SP2; Leica). For experiments with HCT 116 cells, an 
Apochromat 63× 1.3 NA immersion objective was used, whereas for the 
analysis of GFP-LC3 mice tissue sections, an Apochromat 40× 1.15 NA 
immersion objective was used. All the acquisitions were made at RT with 
fixed cells/tissue slides. Images were acquired with a camera (DFC 350 FX 
1.8.0; Leica) using LAS AF software (Leica) and processed with Photoshop 
(CS2; Adobe) software. Specifically, picture processing involved cropping 
of representative areas and linear adjustments of contrast and brightness 
and was performed using Photoshop (with equal adjustment parameters for 
all pictures); no explicit  correction was used. Nonconfocal microscopy of 
yeast strains carrying the EGFP-tagged Atg8 protein was performed with a 
microscope (Axioskop; Carl Zeiss, Inc.) using a Plan Neofluar objective 
lens (Carl Zeiss, Inc.) with a 63× magnification and 1.25 NA in oil at RT. 
Images were taken with a camera (SPOT 9.0 Monochrome 6; Diagnostic 
Instruments, Inc.), acquired using the Metamorph software (6.2r4; Univer-
sal  Imaging  Corp.),  and  processed  with  IrfanView  (version  3.97)  and   
Photoshop (CS2) software. Specifically, picture processing involved coloring 
and cropping of representative areas and was performed with IrfanView. 
In addition, linear adjustments of contrast and brightness were applied 
with Photoshop (using equal adjustment parameters for all pictures); no ex-
plicit  correction was used. Nonconfocal microscopy of C. elegans was 
performed with a microscope (AxioImager Z2; Carl Zeiss, Inc.) using a 
Plan Neofluar 40× objective with a 0.75 NA and a 63× Plan Neofluar ob-
jective with an NA of 1.25 in oil at RT. Images were taken with a camera 
(AxioCam MRc5; Carl Zeiss, Inc.) with Axiovision software (Carl Zeiss, 
Inc.) without further processing. The different fluorophores used in this work 
were GFP and RFP for HCT 116 cells, EGFP for yeast experiments, DsRed 
for C. elegans analyses, and GFP for mice tissue sections. Nuclei were 
counterstained by Hoechst (Invitrogen). Immersion oil (Immersol; Carl Zeiss, 
Inc.) was used for all microscopy analyses.
Immunoblotting, immunoprecipitation, and phosphokinase array
For immunoblotting, cells were collected, washed with cold PBS, and lysed 
as previously described (Criollo et al., 2007). 25 µg of protein was then 
separated on 4–12% Bis-Tris acrylamide (Invitrogen) or 12% Tris-glycine 
SDS-PAGE precast gels (Bio-Rad) and electrotransferred to Immobilon mem-
branes (Millipore) according to standard procedures. Unspecific binding 
sites were saturated by incubating membranes for 1 h in 0.05% Tween 20 
(vol/vol in TBS) supplemented with 5% nonfat powdered milk (wt/vol in 
TBS) followed by overnight incubation with primary antibodies specific for 
acetylated lysine, phosphoacetyl-CoA carboxylase a (Ser79), acetyl-CoA 
carboxylase a, phospho-AKT1 (Thr308), AKT1, LC3, phosphomitogen-acti-
vated  protein  kinase  8  (Tyr183/Thr185),  phospho-PRKAA1  (Thr172), 
PRKAA1, cyclin-dependent kinase inhibitor 1B, phosphoprotein tyrosine   
kinase 2  (Tyr402), phosphoribosomal protein S6 kinase (Thr421/Ser424), 
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protease inhibitor cocktail (Complete; Roche). Tissue extracts were then 
centrifuged at 12,000 g at 4°C, and supernatants were collected. Protein 
concentration in the supernatants was evaluated by the bicinchoninic acid 
technique (BCA protein assay kit; Thermo Fisher Scientific).
Quantitative analysis of GFP-LC3 dots in mice tissue sections
To avoid postmortem autophagy induction, dead mice were immediately 
perfused with 4% paraformaldehyde (wt/vol in PBS, pH 7.4). Tissues were 
then harvested and further fixed with the same solution for ≥4 h followed 
by treatment with 15% sucrose (wt/vol in PBS) for 4 h and with 30% su-
crose (wt/vol in PBS) overnight. Tissue samples were embedded in Tissue-
Tek  OCT  compound  (Sakura)  and  stored  at  70°C.  5-µm-thick  tissue 
sections were generated with a cryostat (CM3050 S; Leica), air dried for 
1 h, washed in PBS for 5 min, dried at RT for 30 min, and mounted with 
Vectashield antifading medium. In each organ, the number of GFP-LC3 
dots was counted in five independent visual fields from at least five mice 
using a confocal fluorescence microscope (TCS SP2).
SILAC sample processing and analysis
Upon digestion, peptides were concentrated and desalted on SepPak C18 
(Waters) purification cartridges and eluted using a highly organic buffer 
(80% acetonitrile and 0.5% acetic acid). Eluates were lyophilized in a   
vacuum centrifuge, dissolved in immunoprecipitation buffer (50-mM MOPS, 
pH 7.2, 10-mM sodium phosphate, and 50-mM sodium chloride), and 
mixed with anti–acetyl lysine antibodies conjugated to agarose beads. The 
mixture was left for 12 h at 4°C on a rotation wheel. The flow-through 
(containing nonbound peptides) was removed, and beads were washed 
four times with the immunoprecipitation buffer and twice with deionized 
water. Bead-bound peptides were eluted with 0.1% trifluoroacetic acid. 
The same enrichment procedure was performed again on the flow-through 
containing the unbound peptides from the first enrichment. Six eluates and 
three separately collected digested protein samples were desalted using 
SepPak C18 cartridges, and 5% of each acetyl lysine–enriched eluate was 
used for MS analysis. The rest of the samples were subsequently separated 
into 12 fractions by isoelectric focusing using the 3100 OFFGEL Fraction-
ator (Agilent Technologies) as previously described (Hubner et al., 2008). 
Gel strips and amfolyte buffer were purchased from GE Healthcare. Focus-
ing was performed for 20 kV/h at a maximum current of 50 µA and maxi-
mum power of 200 mW. 10 µl of 10% trifluoroacetic acid was added to 
each fraction and STAGE (stop and go extraction) tipped as previously de-
scribed  (Rappsilber  et  al.,  2007)  before  MS  analysis,  which  was  per-
formed on either an LTQ Orbitrap XL spectrometer (Thermo Fisher Scientific) 
connected to a 1200 Series Nanoflow HPLC system (Agilent Technologies) 
or an LTQ Orbitrap Velos spectrometer (Thermo Fisher Scientific; Olsen   
et al., 2009) connected to an 1100 Series Nanoflow HPLC system (Agilent 
Technologies) using a nanoelectrospray ion source (Thermo Fisher Scien-
tific). Peptides were separated by reversed phase chromatography using 
an in-house–made fused silica emitter (75-µm internal diameter) packed 
with  3-µm  reversed  phase  material  (Reprosil-Pur  C18-AQ;  Dr.  Maisch 
GmbH). Peptides were loaded in 98% solvent A (0.5% acetic acid) fol-
lowed by a 100-min linear gradient to 50% solvent B (80% acetonitrile 
and 0.5% acetic acid). Survey full-scan MS spectra (mass to charge [m/z] 
range of 300–200, with a resolution of 60,000 at an m/z of 400) were 
acquired followed by fragmentation of the 10 (in the case of using the LTQ 
Orbitrap XL) or the 20 (in the case of using the LTQ Orbitrap Velos) most in-
tense multiply charged ions. Ions selected for MS/MS were placed on a 
dynamic exclusion list for 45 s. Real-time internal lock mass recalibration 
was used during data acquisition (Olsen et al., 2005). For unfractionated 
acetyl lysine–enriched eluates, an additional MS analysis was performed 
on the LTQ Orbitrap Velos using higher energy collision dissociation frag-
mentation (normalized collision energy of 40) of the 10 most intense ions 
from each MS spectrum creating MS/MS spectra at a resolution of 7,500. 
All samples used for protein normalization were analyzed on a mass spec-
trometer (LTQ FT ULTRA; Thermo Finnigan) in which the five most intense 
ions from each precursor scan were selected for fragmentation in the LTQ. 
In this case, no real-time lock mass recalibration was used. Reverse-phase 
chromatography settings were the same as described for the analysis per-
formed on the Orbitrap spectrometers.
SILAC data processing
Raw files were processed with MaxQuant v.1.0.13.13 (Cox and Mann, 
2008) into centroided data and submitted to database searching with 
Mascot  v.2.2  (Matrix-Science).  Preprocessing  by  MaxQuant  was  per-
formed to determine charge states, miscleavages, and SILAC states and to 
filter the MS/MS spectra, keeping the six most intense peaks within a 100-D 
bin. Cysteine carbamidomethyl was chosen as a fixed modification, whereas 
Emission intensity was measured on grayscale images with a pixel depth 
of 8 bits (256 shades of gray). We calculated the mean and maximum 
pixel intensity for each embryo in these images using the ImageJ software 
(National Institutes of Health). For each transgenic line, we processed ≥25 
images over at least three independent trials.
C. elegans lifespan analysis
Lifespan assays were performed at 20°C. Synchronous animal populations 
were generated by hypochlorite treatment of gravid adults to obtain tightly 
synchronized embryos that were allowed to develop into adulthood under 
appropriate conditions. Progeny were grown at 20°C through the L4 larval 
stage and then transferred to fresh plates in groups of 10–20 worms per 
plate for a total of 100–150 individuals per experiment. The day of egg 
harvest was set as t = 0. Animals were transferred to fresh plates every 2–4 d 
and were examined every day for touch-provoked movement and pharyn-
geal pumping until death. Worms that died (because of internally hatched 
eggs, extruded gonads, or desiccation upon crawling on the plate edge) 
were censored and incorporated as such into the dataset. Each survival   
assay was repeated at least three times.
SILAC cell culture, sample processing, and analysis
HCT 116 cells were cultured for 2 wk in three different SILAC media 
(Invitrogen) containing either (1) light isotopes of l-arginine and l-lysine 
(Arg0/Lys0),  (2)  l-arginine–
13C6  HCl  (Euroisotop)  and  l-lysine  2HCl 
4,4,5,5-D4 (Arg6/Lys4; Euroisotop), or (3) l-arginine–
13C6
15N4 HCl and   
l-lysine 
13C6
15N4 HCl (Arg10/Lys8; Invitrogen) and complemented as pre-
viously described (Blagoev and Mann, 2006). Cells were treated for 2 h with 
100 µM spermidine (Arg10/Lys8) or 100 µM resveratrol (Arg6/Lys4) 
and then lysed and subdivided in nuclear, mitochondrial, and cytosolic 
fractions as previously described (Gurbuxani et al., 2003). The cytosolic 
fraction was precipitated using ice-cold (20°C) acetone (4 vol of the 
sample extract), vortexed, and placed for 2 h at 20°C. The resulting solu-
tion was centrifuged for 10 min at 16,000 g, and the supernatant was re-
moved.  The  pellet  was  subsequently  washed  twice  with  ice-cold  4:1 
acetone/water. The final pellet was dried using a concentrator (SpeedVac; 
Thermo Fisher Scientific) for 10–15 min. All fractions were dissolved in de-
naturant 6:2-M urea/thiourea (both obtained from Merck), and Benzonase 
(Merck) was added to the nuclear fraction. All steps were performed at RT 
to avoid carbamoylation of amines. Reduction of cysteines was performed 
with 5-mM DTT (Sigma-Aldrich) for 30 min followed by alkylation with   
11-mM iodoacetamide for 20 min in the dark. The proteins were digested 
with 1:100 protease LysC (Wako Chemicals USA, Inc.) for 3.5 h, diluted 
four times with 50-mM ammonium bicarbonate, and then digested with 
1:100 trypsin (Promega) overnight. The nuclear fraction mixture was cen-
trifuged at 10,000 g for 10 min, and the supernatant was filtered through 
a 0.45-µm MillexHV filter (Millipore). From each fraction, 100 µg of di-
gested protein was collected for isoelectric focusing, a step required for 
subsequent normalization. The acetyl lysine peptide enrichment was per-
formed as previously described (Choudhary et al., 2009). After peptide 
enrichment and isoelectric focusing, samples were subjected to MS analy-
sis, and data were processed as described in the next paragraph.
Preparation of cytoplasts
Trypsinized cells previously transfected with GFP-LC3 cDNA were incu-
bated in 3 ml of complete medium supplemented with 7.5 mg/ml cytocha-
lasin  B  for  45  min  at  37°C.  This  cell  suspension  was  layered  onto  a 
discontinuous Ficoll density gradient (3 ml of 55%, 1 ml of 90%, and 3 ml 
of 100% Ficoll; GE Healthcare) in complete medium containing 7.5 mg/ml 
cytochalasin B. Gradients were prepared in ultracentrifuge tubes and pre-
equilibrated at 37°C in a CO2 incubator overnight. Gradients containing 
cell suspensions were centrifugated in a prewarmed rotor (SW41; Beck-
man Coulter) at 100,000 g for 20 min at 32°C. The cytoplast-enriched 
fraction was collected from the interface between 55 and 90% Ficoll layers, 
washed in complete RPMI 1640 medium, and incubated for 4 h at 37°C 
before resveratrol, spermidine, or rapamycin treatment.
Mouse experiments and tissue processing
C57BL/6 mice obtained from Charles River Laboratory were bred and 
maintained according to both the Federation for Laboratory Animal Sci-
ence Associations and the Animal Experimental Ethics Committee guide-
lines. They were housed in a temperature-controlled environment with 12-h 
light/dark cycles and received food and water ad libitum. Mice were injected 
intraperitoneally with 5 or 50 mg/kg spermidine and with 2.5 or 25 mg/kg 
3 h before anesthetization and killing. Mice tissues were immediately frozen 
in liquid nitrogen after extraction and homogenized in a 20-mM Tris buffer, 
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N-terminal acetylation and methionine oxidation were chosen as variable 
modifications. Furthermore, acetylation of light, medium, and heavy iso-
tope lysines (Lys0/Lys4/Lys8) was chosen as a variable modification. Pro-
cessed  MS/MS  spectra  were  searched  against  a  concatenated  target 
decoy database of forward and reversed sequences from the Interna-
tional Protein Index database (152,616 sequences; FASTA file created 
5/6/2008). For the search, trypsin/P + DP was chosen for the in silico 
protein digestion allowing four miscleavages. The mass tolerance for the 
MS spectra acquired in the Orbitrap was set to 7 ppm, whereas the MS/MS 
tolerance was set to 0.6 D for the collision-induced dissociation MS/MS 
spectra from the LTQ and to 0.04 D for the higher energy collision dissocia-
tion MS/MS spectra. Upon peptide search, protein and peptide identifica-
tion was performed given an estimated maximal false discovery rate of 1% 
at both the protein and peptide level. For false discovery rate calculation, 
posterior error probabilities were calculated based on peptides of at least 
six amino acids having a Mascot score of ≥10. For protein quantification, 
only unmodified peptides, peptides modified by N-terminal acetylation, 
and methionine oxidation were calculated. If a counterpart to a given 
lysine-acetylated peptide was identified, this counterpeptide was also ex-
cluded by protein quantitation. According to the protein group assignment 
performed by MaxQuant, both razor and unique peptides are used for 
protein quantification. A minimum of two ratio counts was required for pro-
tein quantification. For quantification of lysine-acetylated sites, the least 
modified peptides were used. The ratios for the sites were normalized by 
the corresponding protein ratios to account for eventual changes in protein 
abundance. In case a protein ratio was not determined, normalization was 
based on a logarithm transformation algorithm as previously described (Cox 
and Mann, 2008).
Cell respiration and mitochondrial substrate oxidations
Cell respiration and mitochondrial substrate oxidation were polarographi-
cally measured at 37°C in 250 µl of a buffer containing 0.3-M mannitol, 
10-mM KCl, 5-mM MgCl2, 1 mg/ml BSA, and 10-mM KH2PO4, pH 7.4 
(Rustin et al., 1994). Respiration was measured on intact cells (final con-
centration of 10
6/ml), which were subsequently permeabilized by 0.01% 
digitonin to study mitochondrial substrate oxidation. 10-mM malate plus 
10-mM glutamate oxidation was measured in the presence of 200-µM ADP. 
10-mM succinate oxidation by digitonin-permeabilized cells was measured 
in the presence of 2-µM rotenone and 200-µM ADP. Sequential addition of 
2-µM oligomycin, a specific inhibitor of the mitochondrial ATPase, and 2-µM 
carbonyl cyanide m-chlorophenyl hydrazone, a potent mitochondrial 
uncoupler, allowed for the determination of the respiratory control value 
associated with succinate oxidation.
Functional analysis of proteins regulated by deacetylation or acetylation
To decipher the functional context of the proteins associated with the drug-
specific regulation of proteins by deacetylation and acetylation, GO term 
(Ashburner et al., 2000) enrichment was performed using the Cytoscape 
(Shannon et al., 2003) plugin BiNGO (Biological Networks Gene Ontol-
ogy tool; Maere et al., 2005) and PANTHER (Protein Analysis Through 
Evolutionary Relationships) classification system. For the enrichment analy-
sis, proteins regulated by ≥1.5-fold were included, and p-values were cal-
culated by Fisher’s exact test after the Benjamini–Hochberg adjustment for 
multiple testing (Benjamini and Hochberg, 1995). A significance level of 
0.05 (corresponding to the maximal false discovery rate) and a minimum 
of five proteins in at least one of the subsets of each given significant GO 
term were set as thresholds.
Statistical analysis
Statistical  analyses  were  performed  using  the  Prism  software  package 
(GraphPad Software, Inc.), the Office 2003 Excel software package 
(Microsoft), and the statistical environment R (R Development Core Team).   
In cell culture experiments, values were compared using unpaired Student’s 
t tests. For multiple comparisons, we used the one-factor analysis of vari-
ance corrected by posthoc Bonferroni test. C. elegans survival curves were 
created using the product-limit method of Kaplan and Meier. The log-rank 
(Mantel–Cox) test was used to evaluate differences between survival and 
determine p-values.
Online supplemental material
Fig. S1 describes the kinetics of autophagy induction after 100-µM resvera-
trol and spermidine treatment and shows measurements of cell respiration 
and mitochondrial substrate oxidation in the absence (control) or presence 
of 100-µM resveratrol or spermidine. Fig. S2 shows the measurement   
of SILAC fraction purity and analysis of the acetylation status of autoph-
agy essential proteins after spermidine and/or resveratrol treatment. 
Fig. S3 schematically shows the biological processes associated with the 
differentially acetylated proteins in response to resveratrol and spermidine 
treatment by means of GO enrichment. Table S1 shows all the detected acetyl 
lysine–containing motifs in the different subcellular compartments after sper-
midine or resveratrol treatment and their relative enrichment in treated sam-
ples as compared with the corresponding control. Table S2 shows the list 
of proteins belonging to the human autophagy network interacting with the 
proteins detected in SILAC analysis. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.201008167/DC1.
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